Do i have insulin resistance if you're on a GLP-1 like semaglutide or tirzepatide

Understanding Insulin Resistance and GLP-1 Medications

As the founder of CFP Weight Loss and author of The Metabolic Reset Protocol, I often hear this question from adults in their late 40s and early 50s who are managing insulin resistance alongside diabetes, blood pressure issues, and stubborn weight. The short answer: yes, you can still have insulin resistance even while taking GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound). These medications do not cure the underlying cellular issue but dramatically improve how your body handles it.

Insulin resistance occurs when your muscle, fat, and liver cells stop responding efficiently to insulin, forcing your pancreas to produce more. Over years this leads to higher blood sugar, fatigue, and weight gain around the midsection. GLP-1 drugs mimic gut hormones that slow gastric emptying, reduce appetite, and stimulate insulin release only when glucose is present. Clinical data shows they lower HOMA-IR scores (a common measure of insulin resistance) by 20-40% within six months, yet many patients still register above the healthy threshold of 1.9.

Signs You May Still Have Insulin Resistance on These Medications

Even with impressive weight loss of 15-20% body weight, watch for these red flags: persistent sugar cravings after meals, energy crashes mid-afternoon, belly fat that refuses to budge, fasting glucose above 100 mg/dL, or triglycerides over 150 mg/dL. Hormonal changes in perimenopause and menopause amplify these effects, making insulin resistance harder to reverse without targeted lifestyle changes. Joint pain often limits movement, so traditional exercise feels impossible—yet gentle strength training twice weekly can improve cellular insulin sensitivity by up to 25%.

How CFP Weight Loss Helps You Address Root Causes

In The Metabolic Reset Protocol, I outline a simple three-phase approach that works alongside GLP-1 therapy without complicated meal plans. Phase one focuses on 10-minute daily walks after meals to blunt glucose spikes. Phase two adds 25-30 grams of protein at breakfast to stabilize blood sugar for 4-5 hours. Phase three incorporates resistance-band exercises you can do at home in 12 minutes to rebuild muscle mass, which acts as a glucose sink. These steps reduce reliance on higher medication doses and help protect against rebound weight gain if insurance forces discontinuation.

Practical Next Steps for Long-Term Success

Ask your doctor for a fasting insulin test rather than just A1C—many middle-income patients discover their insulin resistance score remains elevated despite normal blood sugar on tirzepatide. Track waist circumference weekly; losing even one inch correlates with measurable drops in insulin levels. Combine your medication with 7-8 hours of sleep and stress-reduction techniques to counteract cortisol-driven resistance. Thousands in our program have reversed their metabolic markers while using GLP-1s responsibly. The key is treating the medication as a tool, not a standalone solution. Start with one small habit today—your future self will thank you.